Short interest for Limoneira gives investors a sense of the degree to which investors are betting on the decline of Limoneira's stock. Short interest data is updated every two weeks.

Limoneira Stock (NASDAQ:LMNR), Short Interest Report

Limoneira

Limoneira Co is an agribusiness company. The company's operating segments include Fresh Lemons; Lemon Packing; Avocados and Other Agribusiness. It generates maximum revenue from the Fresh Lemons segment.

Earnings

Equities

News

Guidance

Asset Sales

Small Cap

Markets

LMNR

Limoneira Co (NASDAQ: LMNR) reported a Q4 FY23 revenue increase of 4% to $41.4 million, beating the 

On The Market Citrus Fruits Company Limoneira Beats On Q4 Revenue &amp; Posts EPS In-Line: Details

Movers

General

Agribusiness and real estate development company Limoneira Co (NASDAQ: LMNR) shares are surging after the Board of Directors commenced a process to explore potential strategic alternatives 

Why Citrus Fruits Company Limoneira&#39;s Shares Are Seeing Blue Skies Today

Penny Stocks

Intraday Update

Trading Ideas

ADTX

AMPE

BIOR

BODY

BTOG

CLSK

CRIS

CYCN

DELL

DOMO

ESTC

FEBO

FTHM

GLBS

HCDI

IXHL

MARA

MATV

MINM

MRVL

OLPX

OPEN

PACI

PATH

PIXY

POLA

PTON

SMFL

SNGX

TNON

ULTA

UPST

VTVT

VVOS

WHLR

WISH

ZUMZ

Gainers
	Harbor Custom Development, Inc.  (NASDAQ: HCDI) rose 74.2% to $1.50 after surging 24% on Thursday.


Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Limoneira Co

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) reported its Q1 earnings results on Thursday, March 7, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Limoneira beat estimated earnings by 38.0%, reporting an EPS of $-0.18 versus an estimate of $-0.29.
Revenue was up $1.83 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 7.000000000000001% increase in the share price the next day.
Here's a look at Limoneira's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.15</td>
<td>0.15</td>
<td>0.19</td>
<td>-0.35</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.15</td>
<td>0.02</td>
<td>0.21</td>
<td>-0.53</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>37.82M</td>
<td>50.07M</td>
<td>48.24M</td>
<td>37.71M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>41.43M</td>
<td>52.50M</td>
<td>48.07M</td>
<td>37.90M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Limoneira <a href="https://www.benzinga.com/quote/LMNR/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Limoneira Q1 Earnings

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) reported quarterly losses of $(0.180) per share which beat the analyst consensus estimate of $(0.270) by 33.33 percent. The company reported quarterly sales of $39.731 million which missed the analyst consensus estimate of $40.581 million by 2.10 percent. This is a 4.83 percent increase over sales of $37.901 million the same period last year.

Earnings Beats

Earnings Misses

Limoneira Q1 2024 Adj EPS $(0.180) Beats $(0.270) Estimate, Sales $39.731M Miss $40.581M Estimate

AFCG

ALIM

AMTX

AOUT

ARBE

ARCT

ARHS

ASLE

ASPS

AVGO

BBAI

BBCP

BILI

BITF

BNED

BURL

CHMI

CIEN

CINT

CLAR

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

COOK

COST

CTOS

DBVT

DLTH

DOCU

DSGR

DXPE

ELUT

EOLS

EVGN

EYPT

FCEL

FNKO

GEVO

GIFI

GRND

GRNT

GWRE

HBIO

ISDR

JYNT

LCTX

LOCO

LUMO

LVRO

METC

MGNX

MKFG

NAPA

NCSM

NDLS

NEPH

NINE

ONCT

ONCY

OPFI

OPTN

OWLT

PBPB

PHAT

PMTS

PRCH

PowerShares Dynamic Industrials Sector Portfolio

PROF

PRTS

PSFE

RDVT

REAX

REFR

RWAY

SDPI

SGHT

Earnings Scheduled For March 7, 2024

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) is set to give its latest quarterly earnings report on Thursday, 2024-03-07. Here's what investors need to know before the announcement.
Analysts estimate that Limoneira will report an earnings per share (EPS) of $-0.29. 
Limoneira bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.00, which was followed by a 6.88% increase in the share price the next day.
Here's a look at Limoneira's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.15</td>
<td>0.15</td>
<td>0.19</td>
<td>-0.35</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.15</td>
<td>0.02</td>
<td>0.21</td>
<td>-0.53</td>
</tr>
<tr>
<td>Price Change %</td>
<td>7.000000000000001%</td>
<td>-4.0%</td>
<td>-8.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1709744541_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Limoneira were trading at $17.91 as of March 05. Over the last 52-week period, shares are up 13.13%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/LMNR/earnings">To track all earnings releases for Limoneira visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Limoneira

Roth MKM analyst Gerry Sweeney maintains Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) with a Buy and raises the price target from $17 to $23.

Price Target

Analyst Ratings

Roth MKM Maintains Buy on Limoneira, Raises Price Target to $23

Thursday marks the last chance for investors to receive the next dividend payout from Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>). 
<h3>What's Happening</h3>
The company announced on Wednesday that it would pay shareholders a quarterly dividend of 7.5 cents per share. On Friday, Limoneira will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 7.5 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Friday. Shareholders who own LMNR as of the end of Thursday's session are eligible to receive the 7.5 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on January 12, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/quote/LMNR">See current stock movements Limoneira on Benzinga.</a>

Dividends

Limoneira: Dividend Insights

Limoneira Co&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmnr#NASDAQ">LMNR</a>) reported a Q4 FY23 revenue increase of 4% to $41.4 million, beating the&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/23/12/b36352290/limoneira-company-announces-fiscal-fourth-quarter-and-full-year-2023-financial-results" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">consensus of $37.8 million</a>.
Agribusiness revenue rose to $40.1 million from $38.2 million a year ago. in the quarter.
In Q4, the company sold around 550,000 cartons of U.S. packed fresh lemons at a $20.39 average price per carton.&nbsp;
Also, brokered lemons and other lemon sales stood at $14.4 million in the quarter. The company witnessed no avocado revenue in the quarter.
LMNR reported an operating loss of $(9.7) million vs. a loss of $(1.9) million a year ago due to higher costs and expenses.
Adjusted EBITDA loss came in at $(1.3) million in Q4 vs. a loss of $(3.8) million the prior year.
Adjusted EPS loss of $(0.15) came in line&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/calendars/earnings" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">with the consensus</a>.&nbsp;
For FY23, net cash used in operating activities stood at $(15.9) million; as of October 31, 2023, cash in hand stood at $3.6 million.
Outlook: LMNR expects food service business and industry logistics to continue to see a slowdown due to supply chain and inflationary pressures on a global basis.
LMNR projects fresh lemon volumes of 5.0 million to 5.5 million cartons and avocado volumes of&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/calendars/guidance" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">7.0 million to 8.0 million pounds in FY24</a>.
The company expects an estimated 700 acres of non-bearing lemons and avocados to become full-bearing over the next four to five years.
Harold Edwards, President and Chief Executive Officer,said, &quot;We also anticipate selling the remaining two identified non-strategic assets this next fiscal year for an expected $50 million in proceeds.....We have adjusted our cash flow projections to account for increased sales prices and now expect to receive $131 million in total proceeds spread out over nine fiscal years, with approximately $8 million received in fiscal year 2022 and $3 million expected in fiscal year 2024.&quot;
Earlier this month, the Board of Directors commenced a process to explore potential strategic alternatives aimed at&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/markets/equities/23/12/36046659/why-citrus-fruits-company-limoneiras-shares-are-seeing-blue-skies-today" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">maximizing value for stockholders</a>.&nbsp;
Price Action: LMNR shares closed higher by 1.32% at $19.19 on Thursday.
Photo via Company

On The Market Citrus Fruits Company Limoneira Beats On Q4 Revenue & Posts EPS In-Line: Details

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) reported its Q4 earnings results on Thursday, December 21, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Limoneira reported in-line EPS of $-0.15 versus an estimate of $-0.15.
Revenue was up $1.77 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.13 which was followed by a 4.17% drop in the share price the next day.
Here's a look at Limoneira's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.15</td>
<td>0.19</td>
<td>-0.35</td>
<td>-0.10</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.02</td>
<td>0.21</td>
<td>-0.53</td>
<td>-0.32</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>50.07M</td>
<td>48.24M</td>
<td>37.71M</td>
<td>33.43M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>52.50M</td>
<td>48.07M</td>
<td>37.90M</td>
<td>39.66M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Limoneira <a href="https://www.benzinga.com/quote/LMNR/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Limoneira: Q4 Earnings Insights

Guidance
 &nbsp;
The Company's food service business and industry logistics continue to experience slowdown due to supply chain and inflationary pressures on a global basis.
 &nbsp;
The Company expects fresh lemon volumes to be in the range of 5.0 million to 5.5 million cartons for fiscal year 2024. Avocado volumes are expected to be in the range of 7.0 million to 8.0 million pounds for fiscal year 2024.
 &nbsp;
The Company now expects to receive a 14% increase in total proceeds of $131 million from Harvest at Limoneira, LLCB II and East Area II spread out over nine fiscal years, with approximately $8 million received in fiscal year 2022.
 &nbsp;
Updated Harvest at Limoneira Cash Flow Projections (in millions)
 &nbsp;
<figure class="table"> 
<table>
<tbody>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">Fiscal Year</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">2022 Actual</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">2024</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">2025</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">2026</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">2027</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">2028</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">2029</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">2030</td>
</tr>
<tr>
<td colspan="3">Projected Distributions</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">$8</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">$3</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">$8</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">$20</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">$30</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">$32</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">$15</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">$15</td>
</tr>
</tbody>
</table>
</figure>
 &nbsp;
The Company has 700 acres of non-bearing lemons and avocados estimated to become full bearing over the next four to five years, which the Company expects will enable strong organic growth in the coming years. Additionally, the Company plans to expand its plantings of avocados over the next three years and also expects to have a steady increase in third-party grower fruit. The foregoing describes organic growth opportunities and does not include potential acquisition opportunities for the Company in its highly fragmented industry.

Limoneira Now Expects To Receive A 14% Increase In Total Proceeds Of $131M From Harvest At Limoneira, LLCB II And East Area II Spread Out Over Nine Fiscal Years

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) reported quarterly losses of $(0.15) per share which met the analyst consensus estimate. This is a 53.13 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $41.43 million which beat the analyst consensus estimate of $37.82 million by 9.55 percent. This is a 4.48 percent increase over sales of $39.66 million the same period last year.

Limoneira Q4 EPS $(0.15), Inline, Sales $41.43M Beat $37.82M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; NAVIOS MARITIME HLDGS INC COM SHS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NM#NYSE">NM</a>) is estimated to report earnings for its third quarter.
&bull; Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) is projected to report quarterly earnings at $1.07 per share on revenue of $1.27 billion.
&bull; Cintas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) is expected to report quarterly earnings at $3.49 per share on revenue of $2.34 billion.
&bull; CarMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) is estimated to report quarterly earnings at $0.47 per share on revenue of $6.35 billion.
&bull; Apogee Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APOG#NASDAQ">APOG</a>) is likely to report quarterly earnings at $1.10 per share on revenue of $360.98 million.
<h3>Companies Reporting After The Bell</h3>
&bull; Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) is expected to report quarterly loss at $3.59 per share on revenue of $15.32 million.
&bull; Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) is estimated to report quarterly earnings at $0.78 per share on revenue of $12.43 billion.
&bull; AAR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) is likely to report quarterly earnings at $0.81 per share on revenue of $558.10 million.
&bull; Mission Produce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVO#NASDAQ">AVO</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $288.45 million.
&bull; Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $37.82 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

APOG

CETX

CTAS

PAYX

Earnings Scheduled For December 21, 2023

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) is set to give its latest quarterly earnings report on Thursday, 2023-12-21. Here's what investors need to know before the announcement.
Analysts estimate that Limoneira will report an earnings per share (EPS) of $-0.15. 
Limoneira bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.13, which was followed by a 4.17% drop in the share price the next day.
Here's a look at Limoneira's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.15</td>
<td>0.19</td>
<td>-0.35</td>
<td>-0.10</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.02</td>
<td>0.21</td>
<td>-0.53</td>
<td>-0.32</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.17%</td>
<td>-7.89%</td>
<td>4.53%</td>
<td>-8.4%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1703080877_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Limoneira were trading at $19.01 as of December 18. Over the last 52-week period, shares are up 42.61%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/LMNR/earnings">To track all earnings releases for Limoneira visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Preview: Limoneira's Earnings

Agribusiness and real estate development company&nbsp;Limoneira Co&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmnr#NASDAQ">LMNR</a>) shares are surging after the Board of Directors commenced a process to explore potential strategic alternatives&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/23/12/b36043721/limoneira-announces-process-to-explore-strategic-alternatives-to-maximize-value" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">aimed at maximizing value for stockholders.&nbsp;</a>
The alternatives include, but are not limited to, a sale of all or parts of the company, merger, and other potential strategic transactions.
The Board has retained Stephens Inc as its financial advisor and Squire Patton Boggs (US) LLP as its legal advisor to assist with the process.
&quot;Today, we consider ourselves to be in a strong financial position, having recently reduced our net debt position and rightsized the balance sheet through our ongoing strategic shift towards an asset-lighter business model,&rdquo; said Chairperson of the Board Scott S. Slater.
The Board has not set a timetable for the process and gave no assurance that it will result in any transaction or other outcome.
In September, the company reported third-quarter total net revenue of $52.5 million, down from $58.9 million the previous year.
Agribusiness revenue for the third quarter included $24.2 million in fresh lemon sales and $3.5 million in avocado revenue, both sharply down from $27.8 million and $12.6 million in sales last year, respectively.
In the quarterly report, the company noted its food service business and industry logistics continue to experience slowdown due to <a href="https://www.benzinga.com/pressreleases/23/09/b34334385/limoneira-company-announces-third-quarter-fiscal-year-2023-financial-results">supply chain and inflationary pressures on a global basis.</a>
Price Action: LMNR shares are trading higher by 18.52% at $18.02 on the last check Friday.
Photo Via Company

Why Citrus Fruits Company Limoneira's Shares Are Seeing Blue Skies Today

Gainers
<ul>
<li>Harbor Custom Development, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcdi#NASDAQ">HCDI</a>) rose 74.2% to $1.50 after surging 24% on Thursday.</li>
<li>Altimmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alt#NASDAQ">ALT</a>) shares surged 45.5% to $4.60 after the company reported topline results from MOMENTUM 48-week Phase 2 obesity trial of pemvidutide.</li>
<li>ShiftPixy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pixy#NASDAQ">PIXY</a>) gained 44.3% to $12.05 after gaining over 43% on Thursday.</li>
<li>Elastic N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/estc#NASDAQ">ESTC</a>) gained 30.3% to $104.72 after the company reported better-than-expected second-quarter financial results and issued guidance.</li>
<li>UiPath Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/path#NYSE">PATH</a>) shares climbed 25.2% to $24.74 after the company reported upbeat third-quarter financial results on Thursday.</li>
<li>Cyclerion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cycn#NASDAQ">CYCN</a>) rose 22.6% to $2.65.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) gained 20.6% to $7.53 following FY23 results.</li>
<li>Tenon Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tnon#NASDAQ">TNON</a>) climbed 20.5% to $2.3490.</li>
<li>Limoneira Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmnr#NASDAQ">LMNR</a>) gained 16.5% to $17.70 as the company announced process to explore strategic alternatives to maximize value.</li>
<li>Globus Maritime Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glbs#NASDAQ">GLBS</a>) gained 15.6% to $2.44.</li>
<li>Samsara Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iot#NYSE">IOT</a>) jumped 14.9% to $31.65 after the company reported better-than-expected third-quarter financial results and issued strong guidance.</li>
<li>Olaplex Holdings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olpx#NASDAQ">OLPX</a>) rose 13.8% to $2.48.</li>
<li>GigaCloud Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gct#NASDAQ">GCT</a>) rose 12.9% to $10.98 after it reported third-quarter FY23 results.</li>
<li>ContextLogic Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wish#NASDAQ">WISH</a>) gained 12.2% to $5.66.</li>
<li>Domo Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/domo#NASDAQ">DOMO</a>) surged 12.3% to $10.66 following quarterly results.</li>
<li>Mativ Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/matv#NYSE">MATV</a>) gained 11.6% to $13.06. Mativ announced completion of sale of Engineered Papers business</li>
<li>Ulta Beauty, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ulta#NASDAQ">ULTA</a>) jumped 10.4% to $470.22 as the company reported upbeat sales results for its third quarter and increased the lower end of its profit and sales projections for the full year. The company also said CFO Scott Settersten plans to retire, effective April 1, 2024.</li>
<li>Upstart Holdings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upst#NASDAQ">UPST</a>) gained 8.8% to $29.13.</li>
<li>Marathon Digital Holdings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) rose 8.2% to $12.95 amid strength in crypto-related stocks as Bitcoin trades near 18-month highs.</li>
<li>Fenbo Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/febo#NASDAQ">FEBO</a>) shares gained 7.8% to $4.79 after falling 11% on Thursday. Fenbo Holdings priced its IPO at $5 per share.</li>
<li>Peloton Interactive Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pton#NASDAQ">PTON</a>) climbed 7.6% to $6.09.</li>
<li>Zumiez Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zumz#NASDAQ">ZUMZ</a>) climbed 7.5% to $20.31 following third-quarter results.</li>
<li>Biora Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bior#NASDAQ">BIOR</a>) shares rose 7.3% to $1.33. Biora Therapeutics secured FDA clearance of IND application for drug/device combination BT-600 targeting treatment of ulcerative colitis.</li>
<li>Opendoor Technologies Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/open#NASDAQ">OPEN</a>) gained 7.3% to $3.23.</li>
<li>HashiCorp Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcp#NASDAQ">HCP</a>) climbed 6.6% to $22.85.</li>
<li>Marriott Vacations Worldwide Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vac#NYSE">VAC</a>) rose 5.3% to $76.78.</li>
</ul>

Losers
<ul>
<li>Polar Power, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pola#NASDAQ">POLA</a>) fell 49.3% to $0.4299. Polar Power priced public offering of 4 million common shares at $0.40 per share for gross proceeds of $1.6 million.</li>
<li>Ampio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ampe#NASDAQ">AMPE</a>) fell 46.2% to $3.0909 after surging 194% on Thursday.</li>
<li>Smart for Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smfl#NASDAQ">SMFL</a>) shares fell 42.7% to $1.38 after gaining over 58% on Thursday.</li>
<li>Incannex Healthcare Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ixhl#NASDAQ">IXHL</a>) shares fell 38.6% to $4.89 after gaining 85% on Thursday.</li>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) shares fell 24.2% to $3.40 after gaining over 386% on Thursday.</li>
<li>Genesco Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gco#NYSE">GCO</a>) fell 20.3% to $29.78 following quarterly results.</li>
<li>Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) fell 17.1% to $0.8125. Soligenix shares jumped 136% on Thursday after the company announced it received FDA IND clearance for the Phase 2 clinical trial of dusquetide in the treatment of aphthous ulcers of Beh&ccedil;et&#39;s disease.</li>
<li>Bit Origin Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btog#NASDAQ">BTOG</a>) dipped 16.5% to $3.89.</li>
<li>Aditxt, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adtx#NASDAQ">ADTX</a>) fell 15.1% to $3.3710 after jumping 15% on Thursday.</li>
<li>PROOF Acquisition Corp I (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/paci#NYSE">PACI</a>) fell 15% to $17.00.</li>
<li>Wheeler Real Estate Investment Trust, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/whlr#NASDAQ">WHLR</a>) shares fell 13.2% to $0.3299 after declining around 25% on Thursday.</li>
<li>Vivos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvos#NASDAQ">VVOS</a>) fell 11% to $21.81.</li>
<li>vTv Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtvt#NASDAQ">VTVT</a>) fell 10.7% to $12.76.</li>
<li>Fathom Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fthm#NASDAQ">FTHM</a>) fell 9.4% to $2.50. Fathom Holdings announced proposed primary and secondary offering of common stock.</li>
<li>The Beachbody Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/body#NYSE">BODY</a>) declined 9.3% to $7.02.</li>
<li>Curis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cris#NASDAQ">CRIS</a>) fell 7.5% to $13.23.</li>
<li>Dell Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dell#NYSE">DELL</a>) fell 4.2% to $72.64. Dell reported upbeat earnings results for its third quarter, while sales missed estimates.</li>
<li>Marvell Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrvl#NASDAQ">MRVL</a>) shares fell 3.8% to $53.63 after the company reported third-quarter earnings results.</li>
</ul>

Now Read This: <a href="https://www.benzinga.com/news/earnings/23/11/36016689/how-to-make-500-a-month-with-pfizer-stock"> How To Make $500 A Month With Pfizer Stock</a>

Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Limoneira Company (the &ldquo;Company&rdquo; or &ldquo;Limoneira&rdquo;) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>), a diversified citrus growing, packing, selling and marketing company with related agribusiness activities and real estate development operations, today announced that its Board of Directors (the &ldquo;Board&rdquo;), with the support of management, has commenced a process to explore potential strategic alternatives aimed at maximizing value for stockholders. As part of this process, the Board is exploring a range of potential alternatives including, but not limited to, a sale of all or parts of the Company, merger, and other potential strategic transactions. The Board has retained Stephens Inc. as its financial advisor and Squire Patton Boggs (US) LLP as its legal advisor to assist with the exploration of alternatives.

Limoneira Announced Process To Explore Strategic Alternatives To Maximize Value

Harold S Edwards, President and CEO at Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>), reported a large insider buy on November 2, according to a new SEC filing. 
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001342423/000110465923113890//Archives/edgar/data/1342423/000110465923113890/0001104659-23-113890-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that Edwards purchased 35,385 shares of Limoneira. The total transaction amounted to $499,990. 
Limoneira shares are trading down 0.0% at $14.39 at the time of this writing on Friday morning.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Important</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. 
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Important Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001342423">Check Out The Full List Of Limoneira's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Limoneira President and CEO Trades $499K In Company Stock

Joint Venture Has Now Closed 707 Residential Unit Sales; Completes Phase 1 at Harvest
Limoneira Company (the "Company" or "Limoneira") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>), a diversified citrus growing, packing, selling and marketing company with related agribusiness activities and real estate development operations, announced today that its real estate development joint venture with The Lewis Group of Companies ("Lewis") closed an additional 121 residential homesites at their Harvest at Limoneira master planned community in Santa Paula ("Harvest"). The 121 closings include 50 homesites purchased by Lennar, and 71 homesites purchased by Richmond American Homes. Both Lennar and Richmond American Homes, two of the country's largest homebuilders, are the primary guest builders at Phase 1 of Harvest. Phase 1 at Harvest is comprised of 707 residential units.
Harold Edwards, President and Chief Executive Officer of the Limoneira Company, stated, "We are very pleased to announce the two closings totaling 121 homesites with our respected guest builders, Lennar and Richmond American Homes. This is our first announcement of homesite closings in fiscal 2023 and completes the sell-out of Phase 1's 707 homesites."
Including today's announcement, Lennar has now purchased a total of 313 residential homesites within Phase 1 at Harvest, and this will be a continuation of Lennar's closed-out Lavender community located within Harvest. The Lavender continuation will include three unique floor plans with three distinct architectural elevations. Richmond American Homes has now purchased a total of 209 residential homesites within Phase 1 at Harvest, and this will be a continuation of Richmond American Home's closed-out Willow community located within Harvest. The Willow continuation will include four unique floor plans with four distinct architectural elevations.
Harvest at Limoneira is a well-balanced, comprehensively designed community providing a range of new housing options near the Pacific Ocean. Boasting scenic views, and close proximity to parks, hiking trails and popular retail destinations, this exceptional community continues to attract strong interest from new home buyers throughout Southern California.

Contracts

Limoneira's Joint Venture With Lewis Group Of Companies Announces Additional 121 Homesite Closings With Lennar And Richmond American Homes

Thursday marks the last chance for investors to receive the next dividend payout from Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>). 
<h3>What's Happening</h3>
The company announced on Wednesday that it would pay shareholders a quarterly dividend of 7.5 cents per share. On Friday, Limoneira will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 7.5 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Friday. Shareholders who own LMNR as of the end of Thursday's session are eligible to receive the 7.5 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on October 20, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/quote/LMNR">Track real-time stock fluctuations for Limoneira on Benzinga.</a>

Thursday Is Your Last Chance To Buy Limoneira Before The Dividend Payout

Limoneira Anticipates Year-Over-Year Pricing Improvement In Fresh Lemons In Q4

Limoneira Now Expects FY23 Fresh Lemon Volumes Of 4.7M-5.0M Cartons, Down From Previous Guidance Of 5.0M-5.4M Cartons

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Passive income usually denotes high-priced blue chips but certain cheap <a href="https://investorplace.com/stock-types/dividend-stocks/">dividend stocks</a> to buy can offer the best of all worlds. Yes, they&rsquo;re risky and you don&rsquo;t want to put all your eggs in one basket. But they can add excitement to an otherwise boring topic.



First, cheap dividend stocks to buy are exactly that &ndash; cheap. Here, I targeted securities that closed under $20 per share for the week ending March 1, just to keep the comparisons nice and tidy.



Second, in part because they&rsquo;re so modestly priced, these cheap dividend stocks to buy offer better upside potential. You might be waiting a long time for your favorite consumer goods stalwart to print a double digital return for the year. With these ideas, you might get that within a quarter or less.



Third and finally, these ideas are generally under the radar. Therefore, if a market slowdown materializes, overexposure to the heavily featured ideas may become problematic. Of course, there are risks with any approach in the market. However, if you don&rsquo;t mind a bit of speculation, these cheap dividend stocks to buy could be right for you.



<h2>Limoneira (LMNR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/05/dividends_1600_kid-300x169.jpg" alt="A photo of a young boy wearing sunglasses, jeans, a blazer, a white shirt and suspenders holding money in various denominations in one hand and sitting in a plush chair."><div>Source: Dmitry Lobanov/Shutterstock.com</div></div>A public limited agribusiness and real estate development company, Limoneira (NASDAQ:<a href="https://investorplace.com/stock-quotes/lmnr-stock-quote/">LMNR</a>) presents an intriguing case for cheap dividend stocks to buy. <a href="https://www.google.com/finance/quote/LMNR:NASDAQ?hl=en">Per its public profile</a>, Limoneira represents one of the largest lemon producers in the world. Given its focus on a key segment of the agricultural industry, LMNR stock enjoys significant relevance. No matter what happens in the market, we&rsquo;ve got to eat.



For the week ending March 1, shares gained just under 1%, closing at $17.97. It&rsquo;s had a rough start to the year, down double-digit percentage points. However, since May 2022, LMNR stock has printed a series of rising lows, which is encouraging. Regarding passive income, the company carries a <a href="https://www.dividend.com/stocks/consumer-staples/consumer-products/agricultural-producers/lmnr-limoneira-co-com/">forward dividend yield of 1.67%</a>.



Admittedly, it&rsquo;s not the most generous yield. However, here&rsquo;s the thing: analysts expect a fairly bright future for the enterprise. Specifically, they anticipate 2024 revenue to reach $199.19 million on average. That would be 10.7% above last year&rsquo;s tally. And 2025 sales could land at just under $217 million.



Also, analysts rate shares a <a href="https://www.tipranks.com/stocks/lmnr/forecast">unanimous strong buy</a> with a $23 average price target.



<h2>Cenovus Energy (CVE)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/11/dividends-1600-300x169.jpg" alt='stock market ticker screen with the word "dividends" appearing in large text. Must-Have Dividend Stocks. Dividend kings to own'><div>Source: iQoncept/shutterstock.com</div></div>A Canadian integrated oil and natural gas company, Cenovus Energy (NYSE:<a href="https://investorplace.com/stock-quotes/cve-stock-quote/">CVE</a>) might seem out of sorts given the broader narrative. Basically, political and ideological winds favor green and sustainable solutions. However, those solutions face significant problems, particularly amid <a href="https://www.bloomberg.com/news/articles/2024-02-01/electric-car-sales-growth-is-slowing-globally-here-s-why">slowing sales of electric vehicles</a>. Therefore, entities like Cenovus have a chance, making CVE one of the cheap dividend stocks to consider.



You don&rsquo;t have to take my word for it. Instead, covering experts of CVE stock believe that on average, Cenovus will print revenue of $40.18 billion by the end of 2024. That would come out to a 4.5% increase over the prior year&rsquo;s result. Looking ahead to 2025, analysts project that sales will land at just under $41 billion.



Again, these are average estimates. On the high side, we&rsquo;re talking about sales of $42.6 billion and $43.88 billion in 2024 and 2025, respectively. Also, analysts anticipate growth in earnings per share in both projected years.



Therefore, Cenovus&rsquo; <a href="https://www.dividend.com/stocks/energy/oil-gas-coal/integrated-oils/cve-cenovus-energy-inc/">forward yield of 2.33%</a>, while low, should be very sustainable. That should be especially true given the lowly payout ratio of 17.3%.



<h2>Barrick Gold (GOLD)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/01/monthly-dividends-300x169.jpg" alt="A hand reaches out of a mailbox holding a wad of cash."><div>Source: Shutterstock</div></div>A tricky but intriguing idea for cheap dividend stocks, Barrick Gold (NYSE:<a href="https://investorplace.com/stock-quotes/gold-stock-quote/">GOLD</a>) is a mining company that produces gold and copper. <a href="https://www.google.com/finance/quote/GOLD:NYSE?hl=en">Per its public profile</a>, Barrick owns 16 operating sites in 13 countries. Fundamentally, Barrick&rsquo;s core commodities should find relevance as many advanced industries require both metals for their physical properties.



Now, GOLD stock is risky because of its poor performance to start 2024. However, in the business week ending last Friday, shares gained just under 3%. It&rsquo;s possible that it could be on a comeback. If so, GOLD&rsquo;s <a href="https://www.dividend.com/stocks/materials/metals-mining/precious-metal-mining/gold-randgold-resources-ltd-adr/">forward dividend yield of 2.68%</a> is attractive. While a bit below the material sector&rsquo;s average yield of 2.82%, Barrick is showing recent signs of market stabilization.



Just as well, analysts have high hopes for the mining enterprise. They anticipate that 2024 sales will land at $12.24 billion, up 7.4% against last year&rsquo;s sales of $11.4 billion. Also, 2025 sales may hit $13.32 billion or nearly 9% up from 2024&rsquo;s projected revenue.



Further, analysts rate GOLD stock a <a href="https://www.tipranks.com/stocks/gold/forecast">consensus strong buy</a> with a $20.31 price target.



<h2>Opera (OPRA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/dividends-definition-300x169.jpg" alt='The word "dividend" highlighted in a dictionary.'><div>Source: Shutterstock</div></div>A multinational technology firm, Opera (NASDAQ:<a href="https://investorplace.com/stock-quotes/opra-stock-quote/">OPRA</a>) offers a range of products and services. These include PC and mobile web browsers, along with news content and an advertisement platform. While OPRA was off to a slow start this year, it recently skyrocketed. In the week ending last Friday, OPRA closed at $14.10, resulting in a return of 30%.



Catapulting sentiment was an <a href="https://www.americanbankingnews.com/2024/03/02/opera-nasdaqopra-sees-strong-trading-volume-on-analyst-upgrade.html">analyst upgrade</a> of OPRA stock, which led to strong trading volume. As well, part of the positive sentiment could center on the realization of potentially robust growth. For 2024, analysts anticipate Opera&rsquo;s revenue to reach $455.34 million, up 14.7% from last year&rsquo;s sales. Looking out to 2025, this metric could spike to $516.8 million or 13.5% up from 2024&rsquo;s projected top-line figure.



Adding to the enthusiasm, the <a href="https://www.tipranks.com/stocks/opra/dividends">dividend yield</a> for OPRA clocks in at 6.93%. In contrast, TipRanks shows that the underlying communication services space averages only 2.54%.



Then you have the analyst rating of a <a href="https://www.tipranks.com/stocks/opra">unanimous strong buy</a>. They anticipate shares to hit $18.88 over the next 12 months, indicating significant upside potential. Thus, it could be one of the cheapest dividend stocks to watch.



<h2>Crescent Point Energy (CPG)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/dividends-300x169.jpg" alt="7 Winning High-Yield Dividend Stocks With Payouts Over 5%"><div>Source: Shutterstock</div></div>An oil and gas company based in Calgary, Alberta, Canada, Crescent Point Energy (NYSE:<a href="https://investorplace.com/stock-quotes/cpg-stock-quote/">CPG</a>) focuses primarily on light oil production in southern Saskatchewan and central Alberta. Yes, it&rsquo;s a hydrocarbon specialist and therefore it clashes with the green and sustainable energy solutions narrative. As stated earlier, though, this narrative is <a href="https://www.reuters.com/business/autos-transportation/industry-pain-abounds-electric-car-demand-hits-slowdown-2024-01-30/">running headfirst into an economic dilemma</a>. Basically, a lot of folks can&rsquo;t afford EVs.



If that&rsquo;s the case, Crescent Point makes a cynically compelling case for cheap dividend stocks. With the infrastructure already present for combustion-powered cars, demand for hydrocarbons could actually rise. And that&rsquo;s exactly what analysts see in 2024, for sales to reach $2.73 billion on average. If so, we&rsquo;re talking about a 16.2% rise from last year&rsquo;s result.



What&rsquo;s even more enticing is the passive income. Right now, Crescent offers a <a href="https://www.dividend.com/stocks/energy/oil-gas-coal/exploration-production/cpg-crescent-point-en/">forward yield of 4.52%</a>. Even better, the payout ratio sits at under 26%. That means yield sustainability shouldn&rsquo;t be a problem for investors.



If that wasn&rsquo;t convincing enough, experts rate CPG a <a href="https://www.tipranks.com/stocks/cpg/forecast">unanimous strong buy</a> with a $9.83 average price target.



<h2>TransAlta (TAC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/dividend-stocks-300x169.jpg" alt='a bag on a table with the word "dividends" on it. represent dividend stocks of all time.'><div>Source: Shutterstock</div></div>An electricity power generator, TransAlta (NYSE:<a href="https://investorplace.com/stock-quotes/tac-stock-quote/">TAC</a>) also specializes in wholesale marketing. According to its <a href="https://www.google.com/finance/quote/TAC:NYSE?hl=en">corporate profile</a>, TransAlta operates 76 power plants in Canada, the U.S., and Australia. Further, it operates wind, hydroelectric, natural gas, and coal power generation facilities. For full disclosure, TAC stock is off to a rough start this year. And last week wasn&rsquo;t pretty, with shares down more than 4%.



So, the reality is that you&rsquo;re going to have to accept huge risks here. However, there is some evidence that since early February, TAC stock has (relatively) stabilized. Nevertheless, analysts are skeptical about TransAlta. For 2024, they project that revenue will slip to $1.99 billion, down almost 20% from last year. And 2025 sales may be even worse, down to $1.81 billion.



Further, for that risk, you&rsquo;re only getting a <a href="https://www.dividend.com/stocks/utilities/power-generation/other/tac-transalta-corp/">forward yield of 2.6%</a>. For the underlying utility sector, the average yield is 3.75%. So, why bother considering TAC as one of the cheap dividend stocks?



It comes down to capital gains potential. Analysts also peg shares a <a href="https://www.tipranks.com/stocks/tac/forecast">unanimous strong buy</a> with a $11.12 price target. From Friday&rsquo;s close, that comes out to almost 63% upside.



<h2>B2Gold (BTG)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/dividends-payment-300x169.jpg" alt='sheet of paper marked "dividends" with a $20 bill on top of it to represent dividend stocks'><div>Source: Shutterstock</div></div>Another precious metals-related enterprise, B2Gold (NYSEAMERICAN:<a href="https://investorplace.com/stock-quotes/btg-stock-quote/">BTG</a>) is a Canadian mining company. <a href="https://www.google.com/finance/quote/BTG:NYSEAMERICAN?hl=en">Per its corporate profile</a>, it owns and operates gold mines in Mali, Namibia, and the Philippines. Fundamentally, the company could rise on inflation continuing to be stickier than expected. Also, policymakers can&rsquo;t afford for the economy to slip into recession. Therefore, borrowing costs may come down, which may be net positive for BTG stock.



While this storyline seems enticing, the problem is the market performance. Simply, B2Gold is off to a disappointing start this year. However, in the business week ending Friday, BTG stock gained over 3%, possibly suggesting a bottom.



Still, it&rsquo;s going to take some convincing of covering experts, who believe that 2024 sales will land at $1.75 billion. That comes out to a decline of 9.5% against last year&rsquo;s tally. However, they also believe that revenue could recover in 2025, generating $2.41 billion.



For accepting the risk, B2Gold offers a <a href="https://www.dividend.com/stocks/materials/metals-mining/precious-metal-mining/btg-b2gold-corp/">forward yield of 6.25%</a>. Also, the payout ratio is very reasonable at only 40.92%.



Finally, analysts rate shares a <a href="https://www.tipranks.com/stocks/btg/forecast">consensus strong buy</a> with a $4.16 price target. Regarding cheap dividend stocks, BTG has a bit of everything.



On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/03/7-cheap-dividend-stocks-to-grab-for-under-20-this-march/">7 Cheap Dividend Stocks to Grab for Under $20 This March</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Cheap Dividend Stocks to Grab for Under $20 This March

Notable earnings after Thursday's close

Limoneira Company Q1 2024 Earnings Preview

Limoneira Company Non-GAAP EPS of -$0.18 beats by $0.09, revenue of $39.7M misses by $0.88M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Limoneira (NASDAQ:<a href="https://investorplace.com/stock-quotes/lmnr-stock-quote/">LMNR</a>) just reported results for the first quarter of 2024.<ul><li>Limoneira reported earnings per share of -18 cents. This was above the analyst estimate for EPS of -29 cents.</li><li>The company reported revenue of $39.73 million.</li><li>This was 0.67% worse than the analyst estimate for revenue of $40.00 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/03/lmnr-stock-earnings-limoneira-for-q1-of-2024/">LMNR Stock Earnings: Limoneira Beats EPS, Misses Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

LMNR Stock Earnings: Limoneira Beats EPS, Misses Revenue for Q1 2024

Limoneira Company (LMNR) Q1 2024 Earnings Call Transcript

Limoneira Company (LMNR) said after close Thursday that it lost $0.18 per share in quarter one 2024. The company reported earnings on an adjusted basis, so it may not be directly comparable to analyst estimates or prior periods.On the revenue line, the company reported $39.7 million, missing estimates by $269 thousand.In t

Limoneira Company Up 3.55% To $18.83 After Earnings Beat

Limoneira Company declares $0.075 dividend

Limoneira Stock: The Citrus King Further Moving Into The Avocado Empire

The latest update is out from Limoneira Co (LMNR). During their Annual Meeting on March 26, 2024, the Company passed several key resolutions, inclu...

Limoneira Co Enhances Governance and Incentive Plans at Annual Meeting

GOLD

OPRA

SWBI

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Limoneira Stock (NASDAQ:LMNR), Short Interest Report

People Also Watch